I-Hyalgan iyisisombululo esivumayo esine-hyaluronate ye-sodium yemvelo (Hyalectin) ecocekileyo kwi-saline yomzimba. I-Hyalgan ngenye ye-hyaluronates esetyenziswe kwi- viscosupplementation -unyango olubandakanya ukujoba i-gel-like substance (hyaluronate) kwidibeneyo ukuze uncedise iimpawu ezihambelayo ze- synovial fluid . I-viscosupplement ejoyiweyo inceda ukukhupha idibene kunye nokubonelela i-lubrification ukwenzela ukunciphisa ukungqubuzana okwenzeka ngokunyakaza.
Nge- osteoarthritis , i-synovial fluid ilahlekelwa iipropati zayo kunye neenjongo ze-viscosupplementation kukubuyisela ezo zakhiwo.
Imiqondiso yeHyalgan
I-Hyalgan ivunyiwe yi-US Food and Drug Administration (FDA) ngoMeyi 28, 1997, njengendlela yokwenza unyango kwi- knee osteoarthritis . Kuthathwa njengonyango, kungekhona isicatshulwa. I-hyaluronate ye-sodium eHyalgan ikhutshwe kwi-como-combs. I-Hyalgan iboniswa kwizigulane ezineentlungu ezihlobene ne-knee osteoarthritis ezingaphumeleli ukufumana ukukhulula ngokunyanga okungekho unyango kunye nezilwanyana ezilula, ezifana ne- acetaminophen .
Ulawulo lweHyalgan
I-Hyalgan ingumjovo we- intra-articular owanikezelwa kanye ngeveki, enye iveki ngaphandle, i-injection e-5. Ezinye izigulane zingaphumelela kwisiphumo esiyimpumelelo emva kwemijikelezo yeveki yesi-3, ngokusekelwe kwiziphumo zophando zezigulane ezithe zafumana ii-injection ezi-3 kwaye zalandelwa iintsuku ezingama-60.
Ukuqapha kunye nezilumkiso
Kukho amanyathelo okuqapha kunye nezilumkiso ezinxulumene ne-Hyalgan intra-articular injections:
- Ukhuseleko kunye nokusebenza kwe-Hyalgan kumalungu angaphantsi kwegolo akuzange ifundwe.
- Ukuba isigulane sinokuphefumula kwiiprotheni ze-avian, iintsiba, okanye amaqanda, injini kufuneka yenziwe ngokuqapha.
- Ku nokuba nosizi okanye ukuvuvukala ngejoyiki ezayo. Kukwacetyiswa, njengazo zonke iinjongo ze-intra-articular, ukuba izigulane azithatha inxaxheba kwimisebenzi enzima okanye yokunyusa ubunzima kwiiyure ezingama-48 emva kwesojojo.
- Ukhuseleko kunye nokusebenza kweenkunkuma ze-Hyalgan azange zenziwe kwiimfazana ezithweleyo, nakwabasetyhini abaqhawulayo. Ukusetyenziswa kwayo akuzange kufundwe kubantwana.
Iimpawu eziPhakathi kunye neziganeko ezimbi
Iziphumo eziqhelekileyo ezichaphazelekayo ezinxulumene ne-Hyalgan injection ziquka imiba yesisu, inhlungu ye-injection site, ukuvuvuka kwamadolo okanye ukuxhala, ukukhwabanisa kwesikhumba, ukukhwabanisa kunye nentloko. Uninzi lweziphumo ezimalunga neempembelelo zendawo ye-injection ezantsi emva kweentsuku ezimbalwa, ngakumbi ngokuphumla nokusetyenziswa kweqhwa. Inqwalaselo kufuneka ihlawulwe kwiimpawu eziqhubekayo kwaye zingabonakalisa into enzima kakhulu, njengokusuleleka okanye isistim yokuphendula. Iziganeko ezinjalo ezinzima zibhekwa njengeziqabile.
Ngaphantsi
I-Hyalgan yayiyi-viscosupplement yokuqala evunyiweyo yi-FDA ngo-Meyi 1997. Ezinye i-viscosupplements ezivunyiweyo ze-FDA kunye nomhla owamkelweyo zibandakanya:
- ISixvisc 08/08/1997
- Supartz 01/24/2001
- IOrthovisc 02/05/2004
- Euflexxa 12/03/2004
Umthombo:
Hyalgan (i-Sodium Hyaluronate). Ulwaziso loLwazi. Fidia Pharma USA. Meyi ebuyekeziwe.